Bosutinib: Development discontinued

Pfizer Inc. (NYSE:PFE), New York, N.Y. Product: Bosutinib ( SKI-606, PF-5208763); Celebrex celexcoxib ( YM177, Celecox); CP-533536 ( CP-533,536); dibotermin alfa; figitumumab ( CP-751,871, CP-75...